Our results show that PSMA-1-MMAE-Pc413 was selectively delivered to PSMA-expressing cancer cells and the combination of Pc413 based-PDT and MMAE-based chemotherapy resulted in synergistic antitumor activity. This evidence concerns the gene FOLH1 and cancer.